HSHP(HSHP)
HSHP
No analyst ratings available
No analyst price targets available for HSHP
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $207M | $198M | $194M | $73M |
| Low | $203M | $148M | $168M | $63M |
| High | $212M | $241M | $216M | $81M |
| EBITDA Avg | $173M | $165M | $162M | $61M |
| Low | $169M | $124M | $141M | $53M |
| High | $177M | $201M | $181M | $68M |
| EBIT Avg | $145M | $138M | $135M | $51M |
| Low | $142M | $103M | $118M | $44M |
| High | $148M | $168M | $151M | $57M |
| Net Income Avg | $92M | $82M | $82M | $-36M |
| Low | $76M | $68M | $68M | $-42M |
| High | $106M | $94M | $94M | $-30M |
| EPS Avg | $2.00 | $1.78 | $1.78 | $-0.79 |
| Low | $1.66 | $1.47 | $1.48 | $-0.91 |
| High | $2.30 | $2.05 | $2.05 | $-0.65 |
| Analysts (Rev / EPS) | 4 / 1 | 5 / 1 | 1 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $60M | $59M | $31M | $36M | $36M | $49M |
| Low | $54M | $54M | $28M | $33M | $32M | $45M |
| High | $63M | $64M | $33M | $39M | $38M | $52M |
| EBITDA Avg | $50M | $50M | $26M | $30M | $30M | $41M |
| Low | $45M | $45M | $24M | $28M | $27M | $37M |
| High | $53M | $54M | $28M | $32M | $32M | $44M |
| EBIT Avg | $42M | $41M | $22M | $25M | $25M | $34M |
| Low | $38M | $38M | $20M | $23M | $23M | $31M |
| High | $44M | $45M | $23M | $27M | $27M | $37M |
| Net Income Avg | $30M | $31M | $3M | $9M | $8M | $22M |
| Low | $27M | $28M | $3M | $8M | $7M | $20M |
| High | $33M | $34M | $4M | $10M | $9M | $24M |
| EPS Avg | $0.64 | $0.66 | $0.07 | $0.18 | $0.18 | $0.47 |
| Low | $0.56 | $0.58 | $0.06 | $0.16 | $0.16 | $0.41 |
| High | $0.70 | $0.72 | $0.08 | $0.20 | $0.20 | $0.51 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |